Effect of clinical pharmacist intervention on compliance of patients with cerebral infarction
-
摘要: 目的 探讨脑梗死患者用药依从性差的相关因素，研究药师用药教育对患者依从性的影响。 方法 选取鼓楼医院2016年1-6月住院的128名因脑梗死复发住院的患者，对患者入院前用药类别和用药方法进行调查。在对患者进行用药教育后第3天和出院后1个月，对患者依从性进行随访。 结果 入院前仅有36.7%的患者坚持每日服药，并对用药方法掌握明显不足。较低的依从性与患者上次住院期间未接受用药教育有关。药师对患者进行用药教育后，患者的依从性显著提升。 结论 药师作为临床诊治的重要一环，进行用药教育对提高患者依从性、减少脑梗死的复发具有重要意义。Abstract: Objective To explore the factors resulting in poor medication compliance in patients with cerebral infarction and study the effect of medication education by pharmacist on the compliance of patients. Methods 128 patients with cerebral infarction recurrence from January to June of 2016 were selected. Patient's medication history and knowledge were evaluated. The compliance was compared before medication education, 3 days and 30 days after medication education. Results Only 36.7% of the patients took drugs every day before hospitalization. The patient's medication knowledge was limited. The poor compliance was related to the absence of medication education. The compliance was improved significantly after medication education. Conclusion Pharmacists play an important role in patient's care. Pharmacists should take responsibility in medication education to improve medication compliance and reduce the recurrence of cerebral infarction.
-
Key words:
- cerebral infarction /
- medication education /
- medication compliance
-
[1] Grunberg SM, Deuson RR, Mavros P, et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics[J]. Cancer, 2004, 100(10):2261-2268. [2] 余华琴,陈华英,任若梅,等. 阿瑞匹坦三联止吐方案用于接受高致吐方案化疗患者的疗效观察[J]. 现代中西医结合杂志,2016,25(3):274-276. [3] 田奕,王平,马丽君.应用R-INVR国际量表评估阿瑞匹坦、欧赛、地塞米松对于乳腺癌患者化疗所致中重度呕吐治疗效果观察[J]. 中国现代医学杂志,2016,26(18):136-139. [4] Hesketh PJ. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting[J]. Cancer Invest, 2000, 18(2):163-173. [5] 于莉,张晓晔.阿瑞匹坦在实体肿瘤化疗止吐治疗的研究进展[J]. 中国肿瘤临床与康复,2016,23(9):1148-1152. [6] Aapro M, Carides A, Rapoport BL, et al. Aprepitant and fosaprepitant:a 10-year review of efficacy and safety[J]. Oncnlogist, 2015, 20(4):450-458. [7] 郑琪,廖子君,李旭,等. 阿瑞匹坦治疗化疗诱导的爆发性恶心呕吐的临床观察[J]. 山西医科大学学报,2016,47(6):539-543. [8] Chu CC, Hsing CH, Shieh JP, et al. The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting[J]. Eur J Pharmacol, 2014, 722:48-54. [9] 丁荣楣,王平,田奕,等. 阿瑞匹坦辅助预防乳腺癌FAC方案化疗致恶心呕吐的临床观察[J]. 疑难病杂志,2015,14(1):45-48. -
点击查看大图
计量
- 文章访问数: 2903
- HTML全文浏览量: 252
- PDF下载量: 428
- 被引次数: 0
下载:
